ArticlePDF Available

Abstract and Figures

Gaining vascular access in a neonate during cardiopulmonary resuscitation is crucial and challenging. Intraosseous (IO) access can offer a fast and reliable method for achieving emergency access for fluids and drugs when venous access fails in a critically ill child. IO access can however result in rare, but serious adverse events including compartment syndrome and amputation. We describe a case resulting in leg amputation due to IO infusion in a neonate after resuscitation and therapeutic hypothermia. We compared 10 tibia X-rays in three age groups. The mean medullary diameter of the proximal tibia at the recommended site for IO access was 7 mm in neonate, 10 mm in 1- to 12-month-old infants, and 12 mm in 3- to 4-year-old children. This provides a narrow margin of safety for the correct positioning and the avoidance of dislodgement of the IO needle. The correct position of the IO needle should be confirmed by bone marrow aspiration and fluid bolus. Unnecessary touching of the IO needle after fixing it in place should be avoided by inserting a luer-lock catheter with a three-way stop-cock for IO drug and fluid administration. Regular observation of the circulation and possible swelling of the leg should be performed. The IO administration of inotropic infusions should also be avoided after the initial resuscitation phase. When treating with therapeutic hypothermia, it may be wise to remove the IO needle much earlier than the currently recommended 24 h because of the problems in peripheral circulation and its monitoring. © 2015 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Content may be subject to copyright.
Intraosseous access in neonates and infants: risk of severe
complications a case report
P. K. Suominen
1
, E. Nurmi
1
and K. Lauerma
2
1
Department of Anaesthesia and Intensive Care, Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
2
HUS Medical Imaging Center, Radiology, Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Correspondence
P. K. Suominen, Department of Paediatric
Anaesthesia and Intensive Care, Children’s
Hospital, Helsinki University Hospital,
University of Helsinki, Stenb
ackinkatu 11,
FI-00029 Helsinki, Finland
E-mail: pertti.suominen@hus.fi
Conflicts of interest
All the authors have no financial or other
relationships that might pose a conflict of
interest.
Submitted 20 July 2015; accepted 2 August
2015; submission 19 April 2015.
Citation
Suominen PK, Nurmi E, Lauerma K.
Intraosseous access in neonates and infants:
risk of severe complications a case report.
Acta Anaesthesiologica Scandinavica 2015
doi: 10.1111/aas.12602
Gaining vascular access in a neonate during cardiopulmonary
resuscitation is crucial and challenging. Intraosseous (IO) access
can offer a fast and reliable method for achieving emergency
access for fluids and drugs when venous access fails in a critically
ill child. IO access can however result in rare, but serious adverse
events including compartment syndrome and amputation. We
describe a case resulting in leg amputation due to IO infusion in
a neonate after resuscitation and therapeutic hypothermia. We
compared 10 tibia X-rays in three age groups. The mean medul-
lary diameter of the proximal tibia at the recommended site for IO
access was 7 mm in neonate, 10 mm in 1- to 12-month-old
infants, and 12 mm in 3- to 4-year-old children. This provides a
narrow margin of safety for the correct positioning and the avoid-
ance of dislodgement of the IO needle. The correct position of the
IO needle should be confirmed by bone marrow aspiration and
fluid bolus. Unnecessary touching of the IO needle after fixing it
in place should be avoided by inserting a luer-lock catheter with
a three-way stop-cock for IO drug and fluid administration. Regu-
lar observation of the circulation and possible swelling of the
leg should be performed. The IO administration of inotropic infu-
sions should also be avoided after the initial resuscitation phase.
When treating with therapeutic hypothermia, it may be wise to
remove the IO needle much earlier than the currently recom-
mended 24 h because of the problems in peripheral circulation
and its monitoring.
The intraosseous (IO) route for fluid resuscita-
tion and administration of drugs was introduced
in 1922 and gained popularity during the fol-
lowing decades.
1
The use of IO access subse-
quently decreased with the advances in the
quality of peripheral and central IV catheters.
1
In recent decades, IO access has been estab-
lished as a method for gaining emergency access
for fluids and drugs when venous access fails in
a critically ill patient and its use is recom-
mended by international guidelines.
13
IO
access is recommended in cases for which three
attempts at peripheral venous access have failed
or when >90 s have been spent trying to secure
access.
2
The preferred site for IO access insertion
in neonates and children is the anteromedial
surface of the tibia 12 cm below the tibial
tuberosity, due to the easy accessibility of the
subcutaneous cortex.
14
The distal femur is
another recommended insertion IO site in neo-
nates and children.
14
A low overall complica-
tion rate of 1% has been reported.
1,3,4
Compartment syndrome is a rare, but recognized
complication, however.
1,39
We report a case
Acta Anaesthesiologica Scandinavica (2015)
ª2015 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd 1
CASE REPORT
resulting in leg amputation after IO infusion in
a neonate treated with therapeutic hypothermia
after resuscitation. A signed consent was
received from the parents for the case report.
Case report
A previously healthy 24-day-old boy with a cir-
culatory failure was transported to the emer-
gency room (ER) of a University Hospital. An
intravenous (IV) line was placed in the scalp
vein. Suddenly supraventricular tachycardia
(SVT) was converted to a brief episode of ven-
tricular tachycardia and finally pulseless electri-
cal activity. CPR was started immediately. Two
doses of adrenaline and Ringer acetate bolus
10 ml/kg was given before the IV line stopped
functioning. The extremities of the neonate were
cold and the peripheral veins were not visible.
IO access at the left proximal tibia was placed
by an anesthetist using a power-driven device
EZ-IO (Vidacare, San Antonio, TX, USA) and a
15 mm needle. Unfortunately, after a fluid bolus
of 5 ml, the calf of the neonate became swollen
and the IO needle was removed. Another
15 mm IO needle was placed into the left distal
femur. A return to spontaneous circulation was
achieved after 18 min of CPR. The femoral IO
access was functioning well until the baby
started moving his limbs, which caused the dis-
lodgement of the IO needle. Therefore, a third
(15 mm needle) IO access was placed into the
right tibia. Bone marrow was easily drawn into
a syringe and a fluid bolus was easily injected.
Furthermore, a good haemodynamic response to
adrenaline bolus was achieved. An arterial
catheter was subsequently placed into the right
femoral artery.
The neonate was transferred to a pediatric
intensive care unit, where he was intubated,
ventilated and an adrenaline-infusion was
administered via the IO needle. Therapeutic
hypothermia (3234°C) was started and lasted
for 24 h. Several attempts to place a femoral
central line with ultrasound guidance failed.
Jugular or subclavian veins were not accessed
because of the risk of triggering a new episode
of SVT. Therefore, a continuous adrenaline-infu-
sion 0.15 lg/kg/min and noradrenaline-infusion
0.1 lg/kg/min were administered via the IO
needle instead of peripheral IV catheters.
After 24 h of therapeutic hypothermia, the
patient was slowly warmed over the next 12 h.
A serious complication of the right lower limb
was noticed 24 h after placement of the IO nee-
dle. The limb was cold and pale with a clear
demarcation line below the IO needle insertion
place was detected. The IO needle was removed
and anticoagulation with subcutaneous enoxa-
parin 0.5 mg/kg was started. Ultrasound-guided
central venous access was achieved in the right
femoral vein. Two days after the placement of
the IO needle epidermolysis of the skin of the
right distal limb was detected (Fig. 1). An
angiography and several fasciotomies of the
right limb muscles were performed in the opera-
tion room (OR). The circulation was thought to
be sufficient in the right limb. However, 5 days
after the placement of the IO needle during the
second operation all lower limb muscle com-
partments were found to be non-viable and an
amputation below the knee was performed. At
1 year of age the child had haemodynamically
recovered and betablocker medication has been
stopped uneventfully. The child has neurologi-
cally developed according to age and is able to
stand with the lower limb prosthesis and take
assisted steps.
Comparative medulla-diameter measurements
We compared 10 tibia X-rays in three age
groups which were: 1- to 28-day-old full-term
Fig. 1. Ischemia and epidermolysis of the right limb 2 days after the
insertion of the IO needle.
Acta Anaesthesiologica Scandinavica (2015)
2ª2015 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd
P. K. SUOMINEN ET AL.
neonates, 1- to 12-month-old infants, and 3- to
4-year-old children, archived in the database of
the X-ray department. Quantitative measure-
ments of the medullary diameter in antero-pos-
terior and lateral dimensions of these X-rays
were made at the recommended site of IO access
anteromedial surface of the tibia. Children with
syndromes or deformities in lower extremities
were excluded. The measurement site was 1 cm
and 2 cm below the proximal end of the tibia
for neonates and infants respectively, because, it
was not possible to visualize the tibial tuberos-
ity or epiphyseal plate in neonates and infants
in these X-rays (Fig. 2). The measurement site
in 3- to 4-year-old children was 1 cm below the
tibial tuberosity (Fig. 2). The results of the mea-
surements are shown in Table 1.
Discussion
Achieving venous or IO access is challenging
during neonatal resuscitation especially after the
first days after birth, when the readily accessible
umbilical vein is not available.
2,3
IO access can
offer a fast and safe method for gaining an emer-
gency access in a critically ill child.
14
The sinu-
soids and central venous canals in the
medullary cavity of long bones do not collapse
during hypovolemia or shock, unlike the
peripheral veins, which can be seen as a point
in favor of IO access.
1
Unfortunately, the mean
medullary diameter of the proximal tibia at the
recommended site for IO access is only 7 mm in
a neonates and 10 mm in infants (Table 1).
According to a previous study in newborns the
medullary diameter is only 2 mm at the mid-
point of the shaft of the tibia.
10
The length of
the tip of the smallest pediatric needle of the
EZ-IO device, used in the present case was
4 mm. The stylet and Y-shaped needle has to be
placed within the medullary cavity when insert-
ing the needle (Fig. 3). This makes the correct
placement of the IO needle in neonates and
infants and the avoidance of needle dislocation
extremely challenging.
Compartment syndrome is a rare complication
caused by extravasation of fluids and drugs.
Extravasation can be caused by incomplete IO
needle insertion or by penetration of the oppo-
site cortex of the tibia and by producing several
holes in the cortex when attempting IO access
and by needle dislocation after successful place-
ment.
7
In the present case, the first IO insertion
attempt failed but after their initially successful
placements the second and third IO needles
became dislocated during the treatment. Accord-
ing to previous reports semiautomatic devices
may reduce the IO needle insertion time and
the number of insertion attempts needed in
comparison to manual IO devices.
4
Semiauto-
matic devices provide also a more regular entry
site into the cortex, which may minimize the
risk of extravasation.
9
The major emphasis in
neonates and small children must be the correct
positioning of the IO needle and also the pre-
vention of dislodgement rather than the fast
insertion time. The needle is in the bone mar-
row when the needle enters the IO space and a
loss of resistance is detected. When using a
power-driven EZ-IO device in neonates, the
drill has to be stopped within the average mar-
gin of 3 mm so that the needle will remain in
the IO space and not penetrate the opposite cor-
tex. The manufactures of the IO devices such as
AB C
Fig. 2. X-rays of left proximal tibia in
antero-posterior dimension in (a) a neonate,
(b) an infant, and (c) a 3-year-old child.
Acta Anaesthesiologica Scandinavica (2015)
ª2015 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd 3
INTRAOSSEOUS ACCESS IN A NEONATE
the EZ-IO should consider providing different
sizes of IO needles that have been adjusted in
proportion to the patient’s size and that also cor-
responds to the bone marrow space instead of
providing a shorter version of the same caliber
of 15 gage adult needle for neonates and infants
(length 45 mm vs. 15 mm).
In hindsight, several predisposing and dis-
putable factors for this missed and grave
complication could be recognized. The main
issue was that the inotrope infusions were
administered at a slow rate via the IO needle
because the central line could not be placed.
Although, successful IO administration of con-
tinuous infusion of inotropes in an infant with
septic shock has been previously reported,
11
the
slow rate of inotrope infusions in the present
case led to the delayed recognition of signs of
extravasation. It can be speculated that in the
present case the partial dislocation of the
Y-shape tip of the IO needle was such that it
protruded outside of the tibial cortex, and this
may have caused a continuous small leak of the
inotropic infusion. In addition, vasoconstriction
of the lower extremity was further increased by
therapeutic hypothermia of 34°C, which delayed
the detection of poor circulation in the right
limb. The present case emphasizes to use the IO
access primarily for emergency purpose and the
importance of the use of ultrasound guidance
not only to achieve central venous but also
peripheral access.
13
Extravasation that caused compartment syn-
drome, which in the worst case scenario,
resulted in amputation of the leg has been
reported at least six times previously in case
reports,
1,3,4,12
but surprisingly it is not even
mentioned as a possible complication in some
review articles.
59
Almost all of the six previ-
ously reported cases of compartment syndromes
that lead to leg amputations have occurred in
neonates and infants, including one septic shock
survivor that had bilateral below knee amputa-
tions.
59
In addition to large amounts of fluids,
irritating solutions and drugs such as inotropes,
sodium bicarbonate, hypertonic fluids, and cal-
cium have been associated with these incidents
as in the present study.
57
It is highly likely that
the cases with severe compartment syndromes
are underreported, especially when taking into
consideration the most common scenarios of IO
needle placement such as pediatric cardiac arrest
and drowning, which have low survival rates.
This case is presented to raise awareness of
the importance of the correct positioning and
the avoidance of dislodgement of the IO needle
in neonates and infants due to the small medul-
lary space of the neonate tibia. The correct posi-
tion of the IO needle should be confirmed by
bone marrow aspiration and fluid bolus. Unnec-
essary touching of the IO needle after fixing it
in place should be avoided by inserting a luer-
Fig. 3. The 15 mm pediatric needle set of the power-driven device
EZ-IO (Vidacare, San Antonio, TX, USA) with and without the stylet.
The distance between two thin solid lines is 1 mm.
Table 1 Medullary diameter of tibia measured from X-rays at
the preferred site of intraosseous access in neonates and
children (N=30).
Age
Antero-posterior
diameter (mm) Lateral diameter (mm)
<1 month 7.7 0,4 7.4 0.7
112 months 9.9 1.4 9.9 1.5
34 years 12.4 0.8 10.7 1.2
Values are mean SD.
Acta Anaesthesiologica Scandinavica (2015)
4ª2015 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd
P. K. SUOMINEN ET AL.
lock catheter with a three-way stop-cock for the
IO drug and fluid administration. Regular
observation of the circulation and possible swel-
ling of the leg should be performed. The IO
administration of inotropic infusions should
also be avoided after the initial resuscitation
phase. When treating with therapeutic
hypothermia, it may be wise to remove the IO
needle much earlier than the currently recom-
mended 24 h because of the problems in
peripheral circulation and its monitoring.
Because of the low incidence of severe emergen-
cies in neonates and infants, the experience of
IO access insertion remains sparse among physi-
cians. Therefore, regular simulation-based train-
ing with a neonatal mannikin with a real-size
medullary diameter is highly recommended.
References
1. Tobias JD, Ross AK. Intraosseus infusions: a
review for the anesthesiologists with focus on
pediatric use. Anest Analg 2010; 110: 391401.
2. Biarent D, Bingham R, Eich C, Lopez-Herce J,
Maconochie I, Rodriquez-Nunez A, Rajka T,
Zindeman D. European Resuscitation Council
Guidelines for Resuscitation 2010 Section 6.
Paediatric life support. Resuscitation 2010; 81:
136488.
3. Engle WA. Intraosseous access for administration of
medications in neonates. Clin Perinatol 2006; 33:
1618.
4. Olaussen A, Williams B. Intraosseus access in the
prehospital setting: literature review. Prehosp
Disaster Med 2011; 28: 7178.
5. Taylor CC, Clarke NMP. Amputation and
intraosseus access in infants. BMJ 2011;
342: d2778.
6. Vidal R, Kissoon N, Gayle M. Compartment
syndrome following intraosseous infusion.
Pediatrics 1993; 91: 12012.
7. Launay F, Katschburian M, Bourelle S, Jouve JL,
Bollini G. Leg amputation after intraosseous
infusion in a 7-month-old infant: case report. J
Trauma 2003; 55: 78890.
8. Oesterlie GE, Petersen KK, Knudsen L, Henriksen
TB. Crural amputation of intraosseous needle
insertion and calcium infusion. Pediatr Emerg Care
2014; 30: 4134.
9. Dasgupta S, Playfor SD. Intraosseous fluid
resuscitation in meningococcal disease and lower
limb injury. Pediatr Rep 2010; 2: e5.
10. Rodriquez JI, Palacios J, Rodriquez S. Transverse
bone growth and cortical bone mass in the human
prenatal period. Biol Neonat 1992; 62: 2331.
11. Berg RA. Emergency infusion of catecholamines
into bone marrow. Am J Dis Child 1984; 138:
8101.
12. Luck RP, Haines C, Mull CC. Intraosseous access. J
Emerg Med 2010; 39: 46875.
13. Egan G, Healy D, O’Neill H, Clarke-Moloney M,
Grace PA, Walsh SR. Ultrasound guidance for
difficult peripheral venous access: systematic
review and meta-analysis. Emerg Med J 2013; 30:
5216.
Acta Anaesthesiologica Scandinavica (2015)
ª2015 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd 5
INTRAOSSEOUS ACCESS IN A NEONATE
... In a sub-Saharan African neonatal cadaver study, a distance of approximately 10 mm below the tibial tuberosity was recommended for IO insertion [5]. Procedural complications include extravasation that could impact resuscitation efficacy and possibly result in organ loss or bone fractures in 15-30% [6,7]. The NRP guideline lacks clear recommendations regarding needle depth for both term and preterm neonates and does not account for ethnic differences affecting neonatal weight [8]. ...
... IO insertion in neonates can also be challenging due to thinner bones and difficulty sensing change of resistance, which can impact accurate penetration depth [6]. Inappropriate IO insertion sites may lead to severe complications, such as infection, bone fractures, and limb ischemia [6]. ...
... IO insertion in neonates can also be challenging due to thinner bones and difficulty sensing change of resistance, which can impact accurate penetration depth [6]. Inappropriate IO insertion sites may lead to severe complications, such as infection, bone fractures, and limb ischemia [6]. Moreover, data are lacking on success rates of IO needle insertion at recommended sites, especially in Asian neonates, including preterms. ...
Article
Full-text available
Objectives To determine the appropriate intraosseous (IO) needle insertion site, optimal depth and success using a drill-assisted device (DAD) versus a manually inserted needle (MIN). Methods Computed tomography scans of neonatal cadavers were analyzed. Success was based on tibial needle tip placement within the marrow cavity and contrast media distribution. Results Nineteen cadavers (38 tibiae) were included. The overall success rate was comparable between DAD and MIN needles, but reduced in very-low birthweight (VLBW) infants. The insertion site was consistent across birth weight groups. Contrast leakage occurred overall in 15.8% and 41.7% in VLBW infants and was insignificantly greater in DAD versus MIN needles. Minimum and maximum puncture depth was adjusted for higher BW groups. Conclusion IO needles should be placed 2 cm below and 1–2 cm medial to the tibial tuberosity. MIN needles are preferred to minimize leakage. IO depth should be modified by birth weight.
... In newborns, the recommended IO site is the proximal tibia, which has a mean medullary diameter of 7 mm, providing a narrow margin of error to correctly place an IO needle [31]. There are no comparisons between speed of UVC or IO needle placement during neonatal resuscitation available (Table 1). ...
... Case reports have reported extravasation, limb ischemia, compartment syndrome, fractures, infection (local or osteomyelitis), air or fat embolism, and amputation [31,[34][35][36][37]. However, these complications following IO placement are rare, suggesting that IO is a safe and effective alternative if UVC access is unsuccessful or not feasible. ...
Article
b> Background: Epinephrine (adrenaline) is currently the only cardiac agent recommended during neonatal resuscitation. The inability to predict which newborns are at risk of requiring resuscitative efforts at birth has prevented the collection of large, high-quality human data. Summary: Information on the optimal dosage and route of epinephrine administration is extrapolated from neonatal animal studies and human adult and pediatric studies. Adult resuscitation guidelines have previously recommended vasopressin use; however, neonatal studies needed to create guidelines are lacking. A review of the literature demonstrates conflicting results regarding epinephrine efficacy through various routes of access as well as vasopressin during asystolic cardiac arrest in animal models. Vasopressin appears to improve hemodynamic and post-resuscitation outcomes compared to epinephrine in asystolic cardiac arrest animal models. Key Messages: The current neonatal resuscitation guidelines recommend epinephrine be primarily given via the intravenous or intraosseous route, with the endotracheal route as an alternative if these routes are not feasible or unsuccessful. The intravenous or intraosseous dose ranges between 0.01 and 0.03 mg/kg, which should be repeated every 3–5 min during chest compressions. However, the optimal dosing and route of administration of epinephrine remain unknown. There is evidence from adult and pediatric studies that vasopressin might be an alternative to epinephrine; however, the neonatal data are scarce.
... This finding is also in accordance with guidelines (7) in which the maximum use time is 24 h and the ideal removal time is 2 h after arrival at the hospital and replacement with another access method. Suominen et al. (23) suggests aiming for early removal of the IO needle and ensuring vigilant and frequent monitoring of perfusion in the affected extremity. In contrast, Philbeck et al. (24) demonstrated that it might be safe to maintain the EZIO in place for up to 48 h in an adult cohort. ...
Article
Full-text available
Background Vascular access is essential for the efficient treatment of critically ill children, but it can be difficult to obtain. Our study was conducted to analyze the feasibility and short-term safety of intraosseous access (IO) use as well as factors influencing its success and the incidence of complications in pediatric emergencies and resuscitation. This dataset of systematically documented intraosseous access attempts constitutes one of the largest published in the literature. Methods Two-year nationwide prospective surveillance study in Germany from July 2017 to June 2019. Pediatric hospitals anonymously reported the case data of all children aged 28 days to 18 years who arrived with or were treated with an intraosseous access to the German Pediatric Surveillance Unit (GPSU). The main outcomes were the occurrence of complications, overall success and success at the first attempt. The influence of individual factors on outcomes was evaluated using multivariate regression models. Results A total of 417 patients underwent 549 intraosseous access attempts. The overall rates of success and success at the first attempt were 98.3% and 81.9%, respectively. Approximately 63.6% of patients were successfully punctured within 3 min from the time of indication. Approximately 47.7% of IO access attempts required patient resuscitation. Dislocation [OR 17.74 (5.32, 59.15)] and other complications [OR 9.29 (2.65, 32.55)] occurred more frequently in the prehospital environment. A total of 22.7% of patients experienced minor complications, while 2.5% of patients experienced potentially severe complications. Conclusion We conclude that intraosseous access is a commonly used method for establishing emergency vascular access in children, being associated with a low (age-dependent) rate of severe complications and providing mostly reliable vascular access despite a relatively high rate of dislocation.
Chapter
Most neonatal vascular access uses the peripheral or central venous route (e.g., PVAD, CVAD). However, other options are available. Uniquely newborn infants present the opportunity to use the umbilical blood vessels for umbilical venous (UVC) and arterial (UAC) catheters. This chapter considers the insertion, securement, and care of these devices. In addition to UACs, other intra-arterial catheters (IACs) are options. Preventing and limiting the effects of potentially serious risks associated with using specialist vascular access devices are explored. Finally, the chapter briefly considers vascular access in specialist situations and a less usual approach for obtaining access to the vasculature, the intraosseous (IO) route. Specialist vascular access devices play a critical role in delivering therapies and physiological monitoring in emergencies, critical illness, and specialist applications.
Chapter
All medical procedures are associated with known complications, and intraosseous (IO) cannulation is no exception. The complications associated with IO access range from minor complications that are easily treated to life-threatening sequelae. These complications tend to be emphasized by detractors and minimized by advocates of the technique. But a balanced perspective on the relative incidence and severity of line-related complications is essential to proper understanding of the clinical indications for this procedure. This chapter describes the complications associated with the use of IO catheters, including a brief discussion on preferred techniques for reporting of complications and how complication rates may differ according to insertion technique, site selection, and the device used. Historical trends in the rates and reporting of complications from IO infusion are also described, including appropriate methods for reducing the risk of adverse events. Limitations on translating the existing medical literature to clinical care of the critically ill patient are discussed, including recommendations for improved reporting of complications resulting from this potentially lifesaving intervention.
Chapter
Current recommendations for intraosseous (IO) medication administration are largely based upon preclinical animal studies and anecdotal reports of IO medication infusion for patients in emergent situations due to cardiac arrest, hemodynamic instability, respiratory failure, acute pain, poisoning, and neurological emergencies. Although a wide variety of medications have been infused via the IO route, little evidence exists to confirm the general assumption that IO infusion is equivalent to intravenous infusion of emergent medications. This chapter explores current evidence on the IO infusion of various medications and offers insight into how the unique physiologic characteristics of the IO space may prompt the need for consideration of route of infusion when prescribing the dose and timing of various IO medications. Controversies regarding outcomes for patients receiving medication via the IO route, as compared to the direct venous routes, are described. Future directions needed for preclinical and clinical research are also explored.
Article
Full-text available
The red bone marrow (RBM) exposure due to bone-seeking radionuclides can lead to grave medical consequences. In particular, the increased risk of leukemia in people exposed due to contamination of the Techa River in 1950s is associated with the RBM exposure due to 89,90Sr. Improvement of the internal RBM dosimetry methods includes the development of computational phantoms that represent 3D models of the skeletal sites. Modeling radiation transport within such phantoms enables estimation of conversion factors from the radionuclide activity in the bone to the RBM dose rate. This paper is an extension study focused on generating a set of computational phantoms representing skeletons of individuals of different ages. The aim was to develop a computational phantom representing a 5-yearold child for internal RBM dosimetry from incorporated beta emitters. The phantoms of the skeletal sites with active hematopoiesis were created using the original Stochastic Parametric Skeletal Dosimetry (SPSD) method. With this method, every such site represented a set of smaller phantoms of simple geometric shape. RBM distribution across the skeleton, bone size, characteristics of bone micro-architecture, as well as density and chemical composition of the simulated media (RBM, bone) were determined based on the published data. As a result, a computational phantom of the major skeletal sites with active hematopoiesis representing a 5-year-old child was generated that included 43 phantoms of bone fragments. Linear dimensions of phantoms were within 3–75 mm. Micro-architecture parameters varied greatly: BV/TV ratio —13–52%, Tb. Th. — 0.09–0.29 mm, Tb. Sp. —0.48–0.98 mm.
Article
Full-text available
Objective In pediatric emergencies, as in case of shock, the use of intraosseous (IO) route is recommended to get rapid vascular access as soon as possible, as it revealed better outcome. Nevertheless, the IO approach is not used at all and/or is limited because of lack of demand and lack of training on the issue of medical staff. The aim of the study was to test applicable and/or demand of IO in clinics providing pediatric critical care services and assess the opportunities to integrate IO access use in emergency care in Georgia. Methods A quasi-experimental study was conducted, following a training of medical staff to perform IO access procedure. Our study involved 140 children admitted to emergency department, 114 of whom underwent venous access and 26 underwent IO access. Several parameters were monitored and reported. Outcomes were compared between the 2 procedures. Results Use of an IO catheter has significantly altered the clinical outcome of the patient's condition; 35% of the total number of patients needed to continue their treatment in the intensive care unit, whereas 65% of the patient's continued treatment in the various general wards (compared with 99% and 1%, respectively, in intravenous access patients). None of IO patients were transferred to other clinics because of the deterioration of their clinical condition. Complications in the form of local infection were not observed in any of the patients using the IO approach (which is interesting in terms of infection control). Conclusion With proper training and in certain indications, the internationally approved method can be safely used in pediatric emergency management in Georgian and similar country health system contexts. Several urgent conditions with high rates of requiring hospitalization could benefit from the IO approach.
Article
Full-text available
About 10% of newborns require some degree of assistance to begin their breathing, and 1% necessitates extensive resuscitation. Sick neonates are exposed to a number of invasive life-saving procedures as part of their management, either for investigation or for treatment. In order to support the neonates with the maximum possible benefits and reduce iatrogenic morbidity, health-care providers performing these procedures must be familiar with their indications, measurements, and potential complications. Hence, the aim of this review is to summarise ten of the main neonatal intensive care procedures with highlighting of their indications, measurements, and complications. They include the umbilical venous and arterial catheterizations and the intraosseous line which represent the principal postnatal emergency vascular accesses; the peripherally inserted central catheter for long-term venous access; the endotracheal tube and laryngeal mask airway for airway control and ventilation; chest tube for drainage of air and fluid from the thorax; and the nasogastric/orogastric tube for enteral feeding. Furthermore, lumber puncture and heel stick were included in this review as very important and frequently performed diagnostic procedures in the neonatal intensive care unit.
Article
Full-text available
Vascular access in critically ill children is a priority for emergency administration of fluid and therapeutic agents. Intraosseous access is an alternative when attempts at venous access fail. The proximal tibia is the preferred site for intraosseous needle insertion, with an accessible subcutaneous cortex. Manual insertion of the intraosseous needle can be supplemented with approved impact driven and power driven needle systems. Intraosseous access has low failure and complication rates, but compartment syndrome has been reported in association with this procedure, and preventive measures have been recommended. Three cases of amputation have been reported, preceded by clinical features of compartment syndrome within a few hours of admission. We describe two cases of leg amputation after intraosseous infusion to emphasise the risk of limb ischaemia during paediatric resuscitation by this route.
Article
Full-text available
We set out to review the recent incidence of extravasation and compartment syndrome in children with meningococcal disease admitted to our Paediatric Intensive Care Unit (PICU) who had been resuscitated with intraosseous (IO) needles. Over a 12-month period, 18 children were admitted to PICU with meningococcal sepsis. Four of these children were resuscitated with IO needles and 2 developed serious complications as a result of extravasation and compartment syndrome. Clinical practice guidelines for children with severe sepsis advocate aggressive early fluid resuscitation therapy. We have identified extravasation and lower limb injury as a potential issue of increasing concern with appropriate aggressive IO fluid resuscitation in severe septic shock in children. Powered IO access systems such as the EZ-IO system offer advantages in terms of placement speed, accuracy and bone entry site profile at minimal extra financial cost.
Article
Intraosseous needle insertion and infusion is considered an easy and reliable method of achieving a vascular access in acute circulatory collapse where other methods have not been successful within reasonable time. Complications are considered few but may be serious. We present a case of a newborn girl, where intraosseous cannulation of the tibia was lifesaving. Despite following most standard recommendations, the treatment resulted in transtibial amputation due to necrosis. We suspect that the necrosis was a consequence of extravasation of tissue-toxic calcium infusion.
Article
Background: Establishing intravenous access is often vital in an acute hospital setting but can be difficult. Ultrasound-guided cannulation increases success rates in prospective studies. However, these studies have often lacked a comparative group. This systematic review and meta-analysis aimed to determine the clinical effectiveness of Ultrasound-guided peripheral intravenous cannulation compared with the standard technique in patients known to have difficult access. Methods: Electronic abstract databases, trial registries, article reference lists and internet repositories were searched using the following search terms: 'peripheral venous cannulation', 'peripheral venous access'. Studies meeting the following criteria were included: randomised controlled trial patients of all ages who required peripheral intravenous access; interventions were Ultrasound-guided versus standard cannulation technique; patients were identified as having difficult venous access; inclusion of at least one defined outcome (procedural success time to cannula placement; number of attempts). Results: 7 trials were identified (289 participants). Ultrasound guidance increases the likelihood of successful cannulation (pooled OR 2.42; 95% CI 1.26 to 4.68; p=0.008). There were no differences in time to successful cannulation, or number of percutaneous skin punctures. Conclusion: Ultrasound guidance increases the likelihood of successful peripheral cannulation in difficult access patients. We recommend its use in patients who have difficult venous access, and have failed venous cannulation by standard methods. Further randomised controlled trials (RCTs) with larger sample sizes would be of benefit to investigate if Ultrasound has any additional advantages in terms of reducing the procedure time and the number of skin punctures required for successful venous cannulation.
Article
Although the majority of Australian intensive care paramedics use the manual intraosseous infusion technique (MAN-IO), several other semiautomatic devices now are available, such as the bone injection gun (BIG) and the semiautomatic intraosseous infusion system (EZ-IO). Given the choice of devices now available, questions have been raised regarding success rates, accuracy, decay of skills, and adverse events.Review the literature regarding the use of intraosseous (IO) devices in the prehospital setting.Selected electronic databases (Medline, Embase, and CINAHL) were searched, and a hand search was conducted for grey-literature that included studies from the commencement of the process to the end of May 2010. Inclusion criteria were any study reporting intraosseous insertion and/or infusion (adult and pediatric) by paramedics in the prehospital setting.The search located 2,100 articles; 20 articles met the inclusion criteria. The review also noted that use of IO access (regardless of technique) offers a safe and simple method for gaining access to the patients’ vascular system. A number of studies found that the use of semiautomatic devices offers better and faster intraosseous access compared with the use of manual devices, and also were associated with fewer complications. The findings also suggest that the use of semiautomatic devices can reduce insertion times and the number of insertion attempts when contrasted with the use of manual insertion techniques. Despite these findings, statistically no specific IO device has proven clinical superiority.While manual IO techniques currently are used by the majority of Australian paramedics, the currently available evidence suggests that semiautomatic devices are more effective. Further research, including cost-benefit analyses, is required at a national level to examine skill acquisition, adverse effects, and whether comparative devices offer clinically significant advantages. A Olaussen, B Williams. Intraosseous access in the prehospital setting: literature review. Prehosp Disaster Med. 2012;27(5):1-5.
Article
A short cut review was carried out to establish which intraosseous device is best for use in the prehospital environment. A total of 2100 papers were found using the reported search, of which 2 represented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses of these best papers are tabulated. The clinical bottom line is that traditional manual intraosseous infusion devices have better success rates and faster insertion times compared with semi-automatic intraosseous infusion devices in the prehospital setting.
Article
Intraosseous (IO) access is used most frequently for emergency care of critically ill infants and children when IV access cannot be rapidly achieved. Despite its efficacy in such situations, applications outside of the emergency room or resuscitation scenario have been limited. Furthermore, although the technique is emphasized in the teaching of those caring for critically ill infants and children in the emergency room or critical care setting, there is limited emphasis on its potential use in the perioperative setting. When peripheral venous access cannot be achieved in the operating room, alternative means of securing vascular access such as central line placement or surgical cutdown are generally successful; however, these techniques may be time consuming. Anyone providing anesthesia care for infants and children may want to become facile with the use of IO infusions for selected indications. We present the history of IO infusions, review the anatomy of the bone marrow space, discuss the potential role of IO infusions in the perioperative period, and analyze its adverse effect profile.
Article
Vascular access is of paramount importance in the care of the critically ill patient. When central or peripheral intravenous access cannot be accomplished in a timely manner, intraosseous access and infusion is a rapid and safe alternative for the delivery of fluids, medications, and blood products. The resurgence of the use of intraosseous access in the 1980s led to the development of new methods and devices that facilitate insertion. This article discusses general indications, contraindications, and complications of intraosseous access and infusion, focusing on new devices and their insertion. Current research is focused on product innovation and improving drug delivery using intraosseous autoinjectors, finding new anatomic sites for placement, and expanding the use of different intraosseous devices to the adult population. CONCLUSIONS/SUMMARY: New, improved intraosseous systems provide health care providers with choices beyond traditional manual intraosseous access for administering fluids.